Ritlecitinib is an oral irreversible JAK3/TEC inhibitor primarily used for the treatment of immune related diseases such as alopecia areata and vitiligo.
The specification of Ritlecitinib is 50mg*28 pills/bottle, which is a common packaging specification, but other specifications may also exist, depending on the market supply situation.
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: